Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing NaN - NaN of 82
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma, Multiple Myeloma in Relapse, Multiple Myeloma With Failed Remission Trial in United States (FOR46)

Completed
  • Multiple Myeloma
  • +2 more
  • San Francisco, California
  • +6 more
Jul 25, 2022

Multiple Myeloma Trial in Worldwide (Lemzoparlimab, Dexamethasone, Carfilzomib)

Terminated
  • Multiple Myeloma
  • Lemzoparlimab
  • +4 more
  • Tucson, Arizona
  • +58 more
Jul 6, 2022

Lymphoma, Multiple Myeloma Trial in Worldwide (Lenalidomide, Dexamethasone, Dexamethasone (Oral))

Completed
Has Results
  • Lymphoma
  • Multiple Myeloma
  • Muscle Shoals, Alabama
  • +215 more
May 5, 2022

Multiple Myeloma Trial in United States (P-BCMA-101 CAR-T cells, Rimiducid)

Terminated
  • Multiple Myeloma
  • Gilbert, Arizona
  • +15 more
May 17, 2022

Multiple Myeloma, AL Amyloidosis, Chronic Lymphocytic Leukemia Trial in Detroit (A single "booster" dose of the Moderna mRNA

Recruiting
  • Multiple Myeloma
  • +2 more
  • A single "booster" dose of the Moderna mRNA COVID-19 vaccine
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Apr 12, 2022

Multiple Myeloma Trial in United States (Elotuzumab in combination with Lenalidomide and Dexamethasone)

No longer available
  • Multiple Myeloma
  • Elotuzumab in combination with Lenalidomide and Dexamethasone
  • Concord, California
  • +26 more
Mar 17, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pom/dex (Pomalidomide plus low dose Dexamethasone))

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • Pom/dex (Pomalidomide plus low dose Dexamethasone)
  • Tucson, Arizona
  • +163 more
Feb 25, 2022

Presentation, Treatment Patterns, and Outcomes in Multiple

Completed
  • Multiple Myeloma
  • No Intervention
  • Little Rock, Arkansas
  • +136 more
Feb 15, 2022

Multiple Myeloma Trial in Worldwide (Melphalan flufenamide (Melflufen), Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Whittier, California
  • +19 more
Feb 2, 2022

Multiple Myeloma Trial in Canada, United States (Pomalidomide, Carfilzomib, dexamethasone)

Recruiting
  • Multiple Myeloma
  • Chicago, Illinois
  • +4 more
Jan 7, 2022

Multiple Myeloma Trial in United States (Lenalidomide, lenalidomide, bortezomib and dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Tucson, Arizona
  • +53 more
Dec 8, 2021

Multiple Myeloma Trial in United States (Elotuzumab, Pomalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Mobile, Alabama
  • +21 more
Jun 10, 2021

Multiple Myeloma Trial in Chicago, Detroit, Poznan (Lenalidomide, Carfilzomib, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Chicago, Illinois
  • +2 more
Jun 29, 2021

Multiple Myeloma Trial in United States (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Daratumumab, Lenalidomide)

Completed
  • Multiple Myeloma
  • Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
  • +4 more
  • Birmingham, Alabama
  • +30 more
Mar 31, 2021

Multiple Myeloma Trial in Boston, Detroit (Dabrafenib, Trametinib)

Unknown status
  • Multiple Myeloma
  • Boston, Massachusetts
  • +1 more
Feb 22, 2021

Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Myeloid Leukemia Trial in Detroit (Dasatinib, laboratory biomarker analysis)

Terminated
  • Non-Hodgkin's Lymphoma
  • +5 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Dec 14, 2020

Multiple Myeloma Trial in France, United States (Oprozomib, Dexamethasone)

Terminated
Has Results
  • Multiple Myeloma
  • Los Angeles, California
  • +12 more
Jun 22, 2020

Hematological Tumors, Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in United States (CC-486, Vidaza)

Completed
  • Hematological Neoplasms
  • +19 more
  • Scottsdale, Arizona
  • +9 more
May 11, 2020

Multiple Myeloma Trial in United States (Lenalidomide)

Completed
Has Results
  • Multiple Myeloma
  • Tucson, Arizona
  • +41 more
Apr 27, 2020

Cancer, Hematologic Malignancies, Multiple Myeloma Trial in Worldwide (Denosumab, Zoledronic acid, Placebo to Denosumab)

Completed
Has Results
  • Cancer
  • +5 more
  • Tucson, Arizona
  • +308 more
Mar 19, 2020

Non-Hodgkin's Lymphoma, Multiple, Mycosis Fungoides Trial in Detroit (Dasatinib)

Terminated
  • Non-Hodgkin's Lymphoma
  • +4 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Mar 12, 2020

Multiple Myeloma Trial in Worldwide (venetoclax, lenalidomide, dexamethasone)

Withdrawn
  • Multiple Myeloma
  • Duarte, California
  • +21 more
Aug 23, 2019

Multiple Myeloma Trial in United States (SGN-CD352A)

Terminated
  • Multiple Myeloma
  • Scottsdale, Arizona
  • +10 more
Aug 8, 2019

S0702: Osteonecrosis of Jaw in Cancer Receiving Zoledronic Acid

Completed
  • Breast Cancer
  • +6 more
  • assessment of therapy complications
  • Anniston, Alabama
  • +452 more
Jul 3, 2019

MMRF Molecular Profiling Protocol

Recruiting
  • Multiple Myeloma
  • Plasma Malignancy
  • genetic sequencing
  • Scottsdale, Arizona
  • +19 more
Mar 15, 2019